LYC Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is April - March.

Millions MYR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	134.52	155.52	128.99	92.28	64.6	26.41
Revenue Growth (YoY)	-13.62%	20.57%	39.78%	42.86%	144.56%	112.43%
Cost of Revenue	78.14	86.55	60.72	50.7	32.41	14.79
Gross Profit	56.38	68.97	68.27	41.58	32.19	11.62
Selling, General & Admin	62.72	68.81	74.67	39.94	32.15	18.8
Other Operating Expenses	-4.75	-4.17	-6.01	-0.15	-7.63	-1.79
Operating Expenses	58.06	64.73	69.94	40.01	24.55	17.01
Operating Income	-1.68	4.24	-1.67	1.57	7.64	-5.39
Interest Expense	-10.29	-10.71	-9.47	-11.22	-8.76	-3.96
Interest & Investment Income	0.2	0.23	0.39	0.26	0.11	0.09
Earnings From Equity Investments	0.02	-0.19	-1.4	-2.23	-0.51	-
Other Non Operating Income (Expenses)	-0.08	-0.08	-0.07	-0.05	-0.05	-0.03
EBT Excluding Unusual Items	-11.83	-6.5	-12.22	-11.67	-1.58	-9.29
Merger & Restructuring Charges	-	-	-0.07	-0.19	-0.29	-0.21
Asset Writedown	-1.59	-1.59	-0.55	-	-	-2.18
Other Unusual Items	-	-	-	-	0.64	0.5
Pretax Income	-13.42	-8.09	-12.84	-11.86	-1.22	-11.18
Income Tax Expense	3.91	4.13	3.68	2.93	3.03	0.28
Earnings From Continuing Operations	-17.33	-12.22	-16.52	-14.8	-4.25	-11.46
Net Income to Company	-17.33	-12.22	-16.52	-14.8	-4.25	-11.46
Minority Interest in Earnings	-3.93	-4.85	-4.26	-4.39	-4.97	-0.4
Net Income	-21.26	-17.07	-20.78	-19.19	-9.23	-11.87
Net Income to Common	-21.26	-17.07	-20.78	-19.19	-9.23	-11.87
Shares Outstanding (Basic)	749	715	715	550	436	362
Shares Outstanding (Diluted)	749	715	715	550	436	362
Shares Change (YoY)	3.81%	-	29.88%	26.33%	20.38%	9.20%
EPS (Basic)	-0.03	-0.02	-0.03	-0.03	-0.02	-0.03
EPS (Diluted)	-0.03	-0.02	-0.03	-0.03	-0.02	-0.03
Free Cash Flow	16.74	23.06	5.03	2.46	-2.54	-5.58
Free Cash Flow Per Share	0.02	0.03	0.01	0.00	-0.01	-0.01
Gross Margin	41.91%	44.35%	52.92%	45.06%	49.83%	44.00%
Operating Margin	-1.25%	2.73%	-1.29%	1.70%	11.83%	-20.39%
Profit Margin	-15.80%	-10.97%	-16.11%	-20.79%	-14.28%	-44.92%
Free Cash Flow Margin	12.45%	14.82%	3.90%	2.67%	-3.93%	-21.14%
EBITDA	5.05	12.37	5.92	4.84	10.4	-3.24
EBITDA Margin	3.75%	7.95%	4.59%	5.24%	16.10%	-12.28%
D&A For EBITDA	6.73	8.13	7.59	3.27	2.76	2.14
EBIT	-1.68	4.24	-1.67	1.57	7.64	-5.39
EBIT Margin	-1.25%	2.73%	-1.29%	1.70%	11.83%	-20.39%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.